The DOI matches its Crossref record.
Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy
Abstract
Clinical data on 7840 HIV-positive patients, representing 43 745 patient-years of follow-up, has been collected. All patients with ARL since 1986 (n = 150) were assessed at presentation for prognostic factors and outcomes recorded. Comparisons are made between cases in the pre-HAART era (1988-1995), and the HAART era (1996-1999). Statistical models are used to calculate the incidence of ARL and factors predicting its development. The incidence of ARL has not changed over time (3 to 7 of 1000 patients per year,P = .933), but contributes to a greater percentage of first AIDS-defining illnesses (ADI) in the HAART era (P ≤ .0001). Older age, nadir CD4 count, and no prior HAART use, predict the development of ARL. There has been no change in stage at presentation, presence of B symptoms, performance status, or marrow involvement between the 2 time cohorts or between patients with or without prior HAART exposure. Similarly, there is no difference in survival duration between the pre-HAART and HAART era (log rankP = .15) or specifically in patients treated with HAART before ARL diagnosis (log rank P = .12). The use of HAART has not yet been shown to influence the incidence or survival of ARL. However, because nadir CD4 count and use of HAART are independent predictors of ARL development, this may translate into a future fall in new cases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
Self-citationOksenhendler, E., Boulanger, E., Galicier, L., Du, M.-Q., Dupin, N., Diss, T. C., Hamoudi, R., Daniel, M.-T., Agbalika, F., Boshoff, C., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2331 · Cited by 411
Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy
Besson, C., Goubar, A., Gabarre, J., Rozenbaum, W., Pialoux, G., Châtelet, F.-P., Katlama, C., Charlotte, F., Dupont, B., Brousse, N., et al. (2001) · Blood · doi:10.1182/blood.v98.8.2339 · Cited by 378
Epstein-Barr virus–associated lymphoproliferative disorders
Rezk, S. A., & Weiss, L. M. (2007) · Human Pathology · doi:10.1016/j.humpath.2007.05.020 · Cited by 298
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy
Kirk, O. (2001) · Blood · doi:10.1182/blood.v98.12.3406 · Cited by 280
Metadata
- Authors
- Matthews, G. V., Bower, M., Mandalia, S., Powles, T., Nelson, M. R., & Gazzard, B. G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2000-10-15
- Volume
- 96
- Issue
- 8
- Pages
- 2730-2734
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W105359055
- Cited by
- 199
- References
- 0
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy. https://app.cochat.ai/papers/10.1182/blood.v96.8.2730
- The paper
- Matthews, G. V., Bower, M., Mandalia, S., Powles, T., Nelson, M. R., & Gazzard, B. G. (2000). Changes in acquired immunodeficiency syndrome–related lymphoma since the introduction of highly active antiretroviral therapy. Blood. https://doi.org/10.1182/blood.v96.8.2730
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.